as well as traditional Chinese medicine formula particles

Sun pharmaceutical (300,026): finishing more than half of xuebijing reproduce high growth is expected to remain at 2011/2012/2013-year EPS forecast of $ 0.91/1.21/1.65, respectively diablo 3 power leveling, its current price corresponds to 11/12/13 annual PE 30/23/17, although old products slipped diablo 3 gold, But we look forward to and bullish channel of xuebijing after finishing opportunities for growth, as well as traditional Chinese medicine formula particles, so we maintain the company's "buy" rating. (Securities Research Institute)